We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current UTMD market cap is 243.21M. The company's latest EPS is USD 4.5832 and P/E is 14.62.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.57M | 12.52M | 12.87M | 12.51M | 12.33M |
| Operating Income | 5.07M | 4.44M | 4.43M | 3.97M | 3.94M |
| Net Income | 4.56M | 4.21M | 4.2M | 3.94M | 4.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 46.9M | 42.18M | 49.05M | 52.28M | 50.22M |
| Operating Income | 17.63M | 13.71M | 18.88M | 19.79M | 16.78M |
| Net Income | 14.73M | 10.8M | 14.79M | 16.47M | 16.64M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 123.87M | 127.77M | 130.48M | 131.24M | 135.46M |
| Total Liabilities | 9.62M | 9.75M | 8.71M | 7.54M | 7.15M |
| Total Equity | 114.25M | 118.02M | 121.76M | 123.7M | 128.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 109.79M | 111.75M | 115.64M | 123.87M | 135.46M |
| Total Liabilities | 8.69M | 8.92M | 8.5M | 9.62M | 7.15M |
| Total Equity | 101.09M | 102.82M | 107.14M | 114.25M | 128.31M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 21.15M | 6.92M | 11.83M | 16.95M | 22.28M |
| Investing | -818k | -43k | -363k | -549k | -639k |
| Financing | -5.48M | -1.05M | -2.06M | -3.09M | -4.17M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 17.06M | 20.14M | 21.2M | 21.15M | 22.28M |
| Investing | -21.54M | -860k | -552k | -818k | -639k |
| Financing | -4.23M | -10.73M | -10.91M | -5.48M | -4.17M |
| Market Cap | 243.21M |
| Price to Earnings Ratio | 14.62 |
| Price to Sales Ratio | 4.84 |
| Price to Cash Ratio | 2.62 |
| Price to Book Ratio | 1.9 |
| Dividend Yield | 1.78% |
| Shares Outstanding | 3.63M |
| Average Volume (1 week) | 22.73k |
| Average Volume (1 Month) | 19.25k |
| 52 Week Change | -27.54% |
| 52 Week High | 100.59 |
| 52 Week Low | 65.78 |
| Spread (Intraday) | 4.59 (6.5%) |
| Company Name | Utah Medical Products Inc |
| Address |
7043 south 300 west midvale, utah 84047 |
| Website | https://www.utahmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
